Valuation: Norda ASA

Market Cap 51Cr 5.3Cr 4.65Cr 4.3Cr 3.95Cr 7.45Cr 511.23Cr 7.57Cr 51Cr 20Cr 250.14Cr 20Cr 19Cr 861.81Cr P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 26Cr 2.73Cr 2.39Cr 2.21Cr 2.03Cr 3.84Cr 263.35Cr 3.9Cr 26Cr 10Cr 128.86Cr 10Cr 10Cr 443.95Cr EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 4.58Cr
-0.49%-4.01%-0.84%+2.28% 4.87TCr
-3.10%-1.94%+370.99%+572.60% 3.84TCr
-0.46%+2.18%+5.44%+61.01% 3.45TCr
-1.14%-1.76%+26.94%-9.93% 3.4TCr
-1.82%-1.43%+0.52%+31.85% 2.68TCr
-3.54%-5.08% - - 1.56TCr
-1.82%-0.43%+69.28%+113.82% 1.51TCr
+1.17%+2.30%+15.87%+18.26% 1.42TCr
-2.25%+0.05%+15.77%-32.83% 1.27TCr
Average -1.01%-1.12%+63.00%+94.63% 2.67TCr
Weighted average by Cap. -1.42%-1.44%+74.77%+116.99%

Financials

2023 2024
Net sales 8.69Cr 89.8L 78.71L 72.75L 66.91L 1.26Cr 87Cr 1.28Cr 8.7Cr 3.41Cr 42Cr 3.37Cr 3.3Cr 145.98Cr 37Cr 3.84Cr 3.37Cr 3.11Cr 2.86Cr 5.4Cr 370.45Cr 5.49Cr 37Cr 15Cr 181.26Cr 14Cr 14Cr 624.48Cr
Net income 3.12Cr 32.2L 28.23L 26.09L 24L 45.28L 31Cr 46L 3.12Cr 1.22Cr 15Cr 1.21Cr 1.18Cr 52Cr 13Cr 1.3Cr 1.14Cr 1.05Cr 96.95L 1.83Cr 125.47Cr 1.86Cr 13Cr 4.94Cr 61Cr 4.89Cr 4.78Cr 211.51Cr
Net Debt -31Cr -3.22Cr -2.82Cr -2.61Cr -2.4Cr -4.52Cr -310.07Cr -4.59Cr -31Cr -12Cr -151.71Cr -12Cr -12Cr -522.7Cr -25Cr -2.57Cr -2.25Cr -2.08Cr -1.92Cr -3.61Cr -247.88Cr -3.67Cr -25Cr -9.76Cr -121.28Cr -9.65Cr -9.44Cr -417.86Cr
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-